— Know what they know.
Not Investment Advice

NMTC NASDAQ

NeuroOne Medical Technologies Corporation
1W: -5.5% 1M: -16.7% 3M: +510.2% YTD: +386.9% 1Y: +524.1% 3Y: +216.8% 5Y: -34.9%
$4.15
+0.00 (+0.00%)
 
Weekly Expected Move ±9.9%
$3 $4 $4 $5 $5
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 40 · $35.4M mcap · 8M float · 0.492% daily turnover · Short 44% of daily vol
Smart Money Score
Watch 0
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$35.4M
52W Range3.276-6.96
Volume35,484
Avg Volume38,479
Beta0.58
Dividend
Analyst Ratings
2 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEODavid A. Rosa
Employees17
SectorHealthcare
IndustryMedical - Devices
IPO Date2018-03-15
Websiten1mtc.com
7599 Anagram Drive
Eden Prairie, MN 55344
US
952 426 1383
About NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

Recent Insider Trades

NameTypeSharesPriceDate
Mills Jason Richard A-Award 41,929 2026-04-03
Mills Jason Richard A-Award 26,036 $0.80 2026-04-03
MATHIESEN JEFFREY S A-Award 41,929 2026-04-03
MATHIESEN JEFFREY S A-Award 26,036 $0.80 2026-04-03
BUCKMAN PAUL A-Award 41,929 2026-04-03

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms